TCL Archive AIDs Concepts Totaling $13 Million Approved By DCT Board; Will Be Funded By Special Appropriations October 11, 1985
TCL Archive Phase III Trial Retrospective Analysis Finds Talimogene Laherparepvec Reduced Tumors March 28, 2014
TCL Archive Study Of Tamoxifen And Raloxifene Enrolls 6,000 In First Year; 5 Percent Are Minorities July 28, 2000